North America Antivenom Market by Type [Vaccines and Hyperimmune Sera (Homologous & Heterologous)] and by Animal (Snakes, Scorpions, Spiders, and Others)- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

North America Antivenom Market by Type [Vaccines and Hyperimmune Sera (Homologous & Heterologous)] and by Animal (Snakes, Scorpions, Spiders, and Others)- Industry Analysis, Size, Share, Growth, Trends, and Forecasts (2016–2021)

ID: 1581 | Pages: 134 | November 2016 | Region: North America


North America Antivenom Market is expected to reach USD 542.4 million by 2021 from USD 427.6 million in 2016, growing at a CAGR of 4.87% during the forecast period 2016-2021. Antivenom is described as the biological product that detoxifies poisoning of venomous bites. Antivenom is prepared from the milking venom of animals such as snakes, spiders, scorpions, and other venomous animals. Venomous bites result in certain clinical conditions such as secretion of excessive saliva, muscle weakness, breathing problems, and other difficulties that may lead to death also. It is estimated that, approximately 3000- 8000 people are recorded with snake bites annually in North America. To overcome poisonous effects after venomous bites manufacturers developed number of Antivenom products including vaccines and hyperimmune sera.

Establishment new snake poison control centres, increasing antivenom products approval, growing research to support the development of effective antivenom products, rising number of clinical trial centres to conduct antivenom products study, increasing fear among people about snake bites, and presence of well-established medical care are driving the growth of North America Antivenom Market. However, stringent regulatory pathways and cost pertaining to manufacturing of antivenom products are expected to restrain the growth of North America Antivenom Market.

North America Antivenom market is broadly categorized into type and animal. On the basis of type, North America Antivenom market is segmented into Vaccines and Hyperimmune Sera (Homologous & Heterologous). Based on animal the market is segmented into Snakes, Scorpions, Spiders, and Others. On the basis of geography, the North America Antivenom market is segmented into United States and Canada.

Key market players in the Antivenom market include Instituto Bioclon, S.A. de C.V. (Mexico), Pfizer AG (Switzerland), CSL Limited (Australia), F. Hoffmann-La Roche Ltd. (Switzerland), Merck & Co., Inc. (U.S.), Rare Disease Therapeutics, Inc. (U.S.), Vins Bioproducts Limited (India), BTG Plc (U.K.), Incepta Vaccine Ltd. (Bangladesh), and Bharat Serum and Vaccines Limited (BSV) (India).

1.Introduction                                  

                1.1 Market Definition                    

                1.2 Study Deliverables                  

                1.3 Base Currency, Base Year and Forecast Periods                           

                1.4 General Study Assumptions                

2. Research Methodology                                           

                2.1 Introduction                              

                2.2 Research Phases                      

                                2.2.1 Secondary Research            

                                2.2.2 Primary Research 

                                2.2.3 Econometric Modelling     

                                2.2.4 Expert Validation  

                2.3 Analysis Design                         

                2.4 Study Timeline                          

3. Overview                                      

                3.1 Executive Summary                

                3.2 Key Inferences                         

                3.3 Epidemology                             

4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)                                      

                4.1 Market Drivers                          

                4.2 Market Restraints                    

                4.3 Key Challenges                         

                4.4 Current Opportunities in the Market               

5. Market Segmentation                                              

                5.1 Type                              

                                5.1.1 Introduction           

                                5.1.2 Vaccines  

                                5.1.3 Hyperimmune Sera             

                                                5.1.3.1 Homologous

                                                5.1.3.2 Heterologous

                                5.1.4 Y-o-Y Growth Analysis, By type       

                                5.1.5 Market Attractiveness Analysis, By Type     

                                5.1.6 Market Share Analysis, By Type      

                5.2 Animal                          

                                5.2.1 Introduction           

                                5.2.2 Snakes      

                                5.2.3 Scorpions

                                5.2.4 Spiders     

                                5.2.5 Others      

                                5.2.6 Y-o-Y Growth Analysis, By Animal  

                                5.2.7 Market Attractiveness Analysis, By Animal

                                5.2.8 Market Share Analysis, By Animal 

6. Geographical Analysis                                              

                6.1 Introduction                              

                                6.1.1 Regional Trends    

                                6.1.2 Impact Analysis     

                                6.1.3 Y-o-Y Growth Analysis        

                                                6.1.3.1 By Geographical Area

                                                6.1.3.2 By Type

                                                6.1.3.2 By Animal

                                6.1.4 Market Attractiveness Analysis      

                                                6.1.4.1 By Geographical Area

                                                6.1.4.2 By Type

                                                6.1.4.2 By Animal

                                6.1.5 Market Share Analysis        

                                                6.1.5.1 By Geographical Area

                                                6.1.5.2 By Type

                                                6.1.5.2 By Animal

                6.2 United States                            

                6.3 Canada                         

7.Strategic Analysis                                        

                7.1 PESTLE analysis                         

                                7.1.1 Political     

                                7.1.2 Economic 

                                7.1.3 Social         

                                7.1.4 Technological         

                                7.1.5 Legal          

                                7.1.6 Environmental      

                7.2 Porter’s Five analysis                              

                                7.2.1 Bargaining Power of Suppliers        

                                7.2.2 Bargaining Power of Consumers    

                                7.2.3 Threat of New Entrants     

                                7.2.4 Threat of Substitute Products and Services

                                7.2.5 Competitive Rivalry within the Industry      

8.Market Leaders' Analysis                                          

                8.1 Instituto Bioclon, S.A. de C.V.                              

                                8.1.1 Overview

                                8.1.2 Product Analysis   

                                8.1.3 Financial analysis  

                                8.1.4 Recent Developments       

                                8.1.5 SWOT analysis       

                                8.1.6 Analyst View          

                8.2 Pfizer AG                     

                8.3 CSL Limited                 

                8.4 Roche                           

                8.5 Merck & Co                

                8.6 Rare Disease Therapeutics, Inc.                         

                8.7 Vins Bioproducts Limited                      

                8.8 BTG Plc                         

                8.9 Incepta Vaccine Ltd                 

                8.10 Bharat Serim and Vaccines Limited (BSV)                    

9.Competitive Landscape                                            

                9.1 Market share analysis                            

                9.2 Merger and Acquisition Analysis                        

                9.3 Agreements, collaborations and Joint Ventures                          

                9.4 New Product Launches                          

10.Market Outlook and Investment Opportunities                                           

Appendix                                           

                a) List of Tables                

                b) List of Figures                              

  • Regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped
  • Segment-level analysis in terms of technology, component, and type along with market size forecasts and estimations to detect key areas of industry growth in detail
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographic, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis
  • Study the micro environment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis and main conclusions
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market
TitlePriceAdd To Cart
  1. North America Antivenom Market By Type, From 2016-2021 ( USD Million )
  2. North America Vaccines Market By Region, From 2016-2021 ( USD Million )
  3. North America Hyperimmune Sera Market By Region, From 2016-2021 ( USD Million )
  4. North America Antivenom Market By Animal, From 2016-2021 ( USD Million )
  5. North America Snakes Market By Region, From 2016-2021 ( USD Million )
  6. North America Scorpions Market By Region, From 2016-2021 ( USD Million )
  7. North America Spiders Market By Region, From 2016-2021 ( USD Million )
  8. North America Others Market By Region, From 2016-2021 ( USD Million )
  9. United States Antivenom Market By Type, From 2016-2021 ( USD Million )
  10. United States Antivenom Market By Animal, From 2016-2021 ( USD Million )
  11. Canada Antivenom Market By Type, From 2016-2021 ( USD Million )
  12. Canada Antivenom Market By Animal, From 2016-2021 ( USD Million )
Middle East And Africa Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Applic...
Latin America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Asia Pacific Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Res...
Europe Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research ...
North America Radioimmunoassay Market By Type (Reagents And Kits Market, Analyzers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Re...
Radioimmunoassay Market By Type (Reagents And Kits Market, Analysers Market), By End-User (Hospital, Pharmaceutical Industry And CRO, Academics And Clinical Diagnostic Laboratories), By Application (Research And Cli...
Middle East And Africa Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, G...
Latin America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Asia Pacific Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Ele...
Europe Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrica...
North America Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric El...
Nerve Repair And Regeneration Market By Product (Internal Neurostimulation Devices Such As Spinal Cord Stimulation, Deep Brain Stimulation, Vagus Nerve Stimulation, Sacral Nerve Stimulation, Gastric Electrical Stimu...

"We Think Through Different Layers, We Work Across Different Verticals."

Market Data Forecast, Inc.
2nd Floor, Lakeview Plaza, Kavuri Hills, Hyderabad, Telangana 500033, India.
+1-888-702-9626 (U.S. TOLL FREE)
contact@marketdataforecast.com


Subscribe To Our News Letter

Or follow us on social platform

© 2017 Market Data Forecast
All Rights Reserved.